{"altmetric_id":21263974,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":33},"twitter":{"unique_users_count":29,"unique_users":["OncotargetACD","CancerWallonia","ImmunePC_Papers","vargas_gardenia","darioT_","FabienReyal","PourcelPourcel8","OncotargetJrnl","JPMM_MD_CICS","rosascorp","CICS_DR_MARQUEZ","Diana_CICS","CICS_DrJulioC","Agutierrez_83","PGVM_CICS","CICS_DLAF","ChoreGalaz","FGM_CICS","LorenaMontijo","AL_CICS","MAT_CICS","AGL_CICS","cpjorgelopez","yvano07","patologia_oma","CICS_TSA","TR_CICS","YC_CICS","pmarignani"],"posts_count":33}},"selected_quotes":["ESR1 PIK3CA mutations in plasma cell-free DNA from ER-positive breast #cancer patients #Oncotar\u2026","PC #Oncotarget Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer\u2026","ESR1 PIK3CA mutations in plasma cell-free DNA from ER-positive breast #cancer patients","Good morning read. Analysis of ESR1 PIK3CA mutations in plasma cfDNA from ER-positive breast cancer patients.","ESR1 PIK3CA mutations in plasma cell-free DNA from ER-positive breast #cancer patients #Oncotarget #science #summer"],"citation":{"abstract":"The measurement of ESR1 and PIK3CA mutations in plasma cell-free DNA (cfDNA) has been studied as a non-invasive method to quickly assess and monitor endocrine therapy (ET) resistant metastatic breast cancer (MBC) patients.\nThe subjects of this retrospective study were a total of 185 plasma samples from 86 estrogen receptor-positive BC patients, of which 151 plasma samples were from 69 MBC patients and 34 plasma samples were from 17 primary BC (PBC) patients. We developed multiplex droplet digital PCR assays to verify the clinical significance of ESR1 and PIK3CA mutations both in a snapshot and serially in these patients.\ncfDNA ESR1 and PIK3CA mutations were found in 28.9% and 24.6 % of MBC patients, respectively. The relation between ESR1 or PIK3CA mutations and clinical features showed that ESR1 mutations occurred mostly in patients previously treated by ET, which was not the case for PIK3CA mutations. The analysis of the clinical impact of those mutations on subsequent lines of treatment for the 69 MBC patients revealed that both ESR1 and PIK3CA mutations detection were related to a shorter duration of ET effectiveness in univariate analysis but only for ESR1 mutations in multivariate analysis. The monitoring of cfDNA in a subset of 52 patients showed that loss of ESR1 mutations was related to a longer duration of response, which was not the case for PIK3CA mutations.\nWe have demonstrated the clinical significance of on-treatment ESR1 mutations both in a snapshot and serially in comparison with PIK3CA mutations.","altmetric_jid":"4f6fa8213cf058f61000bc6f","authors":["Takeshita, Takashi","Yamamoto, Yutaka","Yamamoto-Ibusuki, Mutsuko","Tomiguchi, Mai","Sueta, Aiko","Murakami, Keiichi","Omoto, Yoko","Iwase, Hirotaka","Takashi Takeshita","Yutaka Yamamoto","Mutsuko Yamamoto-Ibusuki","Mai Tomiguchi","Aiko Sueta","Keiichi Murakami","Yoko Omoto","Hirotaka Iwase"],"doi":"10.18632\/oncotarget.18479","first_seen_on":"2017-06-22T12:06:38+00:00","funders":["niehs"],"handles":[],"issns":["1949-2553"],"issue":"32","journal":"Oncotarget","last_mentioned_on":1505121173,"links":["https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28636544?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.impactjournals.com\/oncotarget\/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=18479&path%5B%5D=59405","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28881720?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter"],"pdf_url":"http:\/\/www.impactjournals.com\/oncotarget\/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=18479&path%5B%5D=59404","pmcid":"PMC5581019","pmid":"28636544","pubdate":"2017-06-22T22:01:46+00:00","publisher":"Impact Journals, LLC","subjects":["neoplasms"],"title":"Analysis of <i>ESR1<\/i> and <i>PIK3CA<\/i> mutations in plasma cell-free DNA from ER-positive breast cancer patients","type":"article","volume":"8","mendeley_url":"http:\/\/www.mendeley.com\/research\/analysis-ltigtesr1ltigt-ltigtpik3caltigt-mutations-plasma-cellfree-dna-erpositive-breast-cancer-pati"},"altmetric_score":{"score":17.4,"score_history":{"1y":17.4,"6m":17.4,"3m":17.4,"1m":14.2,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":17.4},"context_for_score":{"all":{"total_number_of_other_articles":8420753,"mean":7.0857638519611,"rank":508491,"this_scored_higher_than_pct":93,"this_scored_higher_than":7911808,"rank_type":"exact","sample_size":8420753,"percentile":93},"similar_age_3m":{"total_number_of_other_articles":237698,"mean":12.960219607315,"rank":25509,"this_scored_higher_than_pct":89,"this_scored_higher_than":212153,"rank_type":"exact","sample_size":237698,"percentile":89},"this_journal":{"total_number_of_other_articles":8924,"mean":3.2219905861257,"rank":187,"this_scored_higher_than_pct":97,"this_scored_higher_than":8737,"rank_type":"exact","sample_size":8924,"percentile":97},"similar_age_this_journal_3m":{"total_number_of_other_articles":955,"mean":4.5010188679245,"rank":32,"this_scored_higher_than_pct":96,"this_scored_higher_than":923,"rank_type":"exact","sample_size":955,"percentile":96}}},"demographics":{"poster_types":{"member_of_the_public":16,"researcher":1,"practitioner":12},"users":{"twitter":{"cohorts":{"Members of the public":16,"Practitioners (doctors, other healthcare professionals)":12,"Scientists":1}},"mendeley":{"by_status":{"Researcher":1},"by_discipline":{"Biochemistry, Genetics and Molecular Biology":1}}},"geo":{"twitter":{"IT":1,"FR":1,"US":1,"MX":9,"CA":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/OncotargetACD\/statuses\/897003402814562304","license":"gnip","citation_ids":[21263974],"posted_on":"2017-08-14T07:54:11+00:00","author":{"name":"Oncotarget ACD","url":"http:\/\/www.impactjournals.com\/oncotarget\/index.php?journal=oncotarget&page=pages&op=view&path%5B%5D=","image":"https:\/\/pbs.twimg.com\/profile_images\/897050007932723201\/5tB9mCZx_normal.jpg","description":"This section of Oncotarget deals with the latest developments in Autophagy and Cell Death Research, not necessarily related to oncology.","id_on_source":"OncotargetACD","tweeter_id":"3400234997","geo":{"lt":null,"ln":null},"followers":4421},"tweet_id":"897003402814562304"},{"url":"http:\/\/twitter.com\/CancerWallonia\/statuses\/897038371809349632","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-14T10:13:08+00:00","author":{"name":"CancerWallonia","image":"https:\/\/pbs.twimg.com\/profile_images\/623178120615604224\/unGEOij0_normal.jpg","description":"Cancer: from Wallonia to the World, from the World to Wallonia -  Cancer: la Wallonie parle au Monde, le Monde parle \u00e0 la Wallonie","id_on_source":"CancerWallonia","tweeter_id":"2848852120","geo":{"lt":null,"ln":null},"followers":631},"tweet_id":"897038371809349632"},{"url":"http:\/\/twitter.com\/ImmunePC_Papers\/statuses\/877859498848690177","license":"gnip","citation_ids":[21263974],"posted_on":"2017-06-22T12:03:09+00:00","author":{"name":"ImmunePCPapers","image":"https:\/\/pbs.twimg.com\/profile_images\/686611418108407809\/IkK2E3oo_normal.jpg","description":"Twitterbot #PC papers #PubMed RSS | \u22652016 | #PlasmaCells are specialized #Bcells that secrete #antibody | Curated @mmw_lmw","id_on_source":"ImmunePC_Papers","tweeter_id":"4735354746","geo":{"lt":null,"ln":null},"followers":53},"tweet_id":"877859498848690177"},{"url":"http:\/\/twitter.com\/OncotargetACD\/statuses\/897003361140174851","license":"gnip","citation_ids":[21263974],"posted_on":"2017-08-14T07:54:01+00:00","author":{"name":"Oncotarget ACD","url":"http:\/\/www.impactjournals.com\/oncotarget\/index.php?journal=oncotarget&page=pages&op=view&path%5B%5D=","image":"https:\/\/pbs.twimg.com\/profile_images\/897050007932723201\/5tB9mCZx_normal.jpg","description":"This section of Oncotarget deals with the latest developments in Autophagy and Cell Death Research, not necessarily related to oncology.","id_on_source":"OncotargetACD","tweeter_id":"3400234997","geo":{"lt":null,"ln":null},"followers":4421},"tweet_id":"897003361140174851"},{"url":"http:\/\/twitter.com\/CancerWallonia\/statuses\/897038408622669824","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-14T10:13:17+00:00","author":{"name":"CancerWallonia","image":"https:\/\/pbs.twimg.com\/profile_images\/623178120615604224\/unGEOij0_normal.jpg","description":"Cancer: from Wallonia to the World, from the World to Wallonia -  Cancer: la Wallonie parle au Monde, le Monde parle \u00e0 la Wallonie","id_on_source":"CancerWallonia","tweeter_id":"2848852120","geo":{"lt":null,"ln":null},"followers":631},"tweet_id":"897038408622669824"},{"url":"http:\/\/twitter.com\/vargas_gardenia\/statuses\/897135314153725954","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-14T16:38:21+00:00","author":{"name":"Gardenia","image":"https:\/\/pbs.twimg.com\/profile_images\/627982773190574080\/Z-wZeTRS_normal.jpg","id_on_source":"vargas_gardenia","tweeter_id":"3095312962","geo":{"lt":null,"ln":null},"followers":57},"tweet_id":"897135314153725954"},{"url":"http:\/\/twitter.com\/darioT_\/statuses\/897376331851337728","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-15T08:36:04+00:00","author":{"name":"Dario Trapani","url":"http:\/\/www.medicinformazione.it\/Home.xhtml","image":"https:\/\/pbs.twimg.com\/profile_images\/881640305585475588\/RZg5Y0wW_normal.jpg","description":"medical #Oncology. Interested in translational medicine, new drugs & low-middle income Countries cancer-programs. University of Milan\/IEO.","id_on_source":"darioT_","tweeter_id":"1718379914","geo":{"lt":45.46427,"ln":9.18951,"country":"IT"},"followers":788},"tweet_id":"897376331851337728"},{"url":"http:\/\/twitter.com\/FabienReyal\/statuses\/897518719328505859","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-15T18:01:52+00:00","author":{"name":"fabien reyal","url":"http:\/\/www.seintinelles.com","image":"https:\/\/pbs.twimg.com\/profile_images\/902999396081643520\/MNsipsjn_normal.jpg","description":"head of breast cancer, gynecologic cancer and reconstructive surgery, institut curie, paris","id_on_source":"FabienReyal","tweeter_id":"1912331911","geo":{"lt":48.85341,"ln":2.3488,"country":"FR"},"followers":164},"tweet_id":"897518719328505859"},{"url":"http:\/\/twitter.com\/PourcelPourcel8\/statuses\/897898257967218688","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-16T19:10:01+00:00","author":{"name":"Pourcel","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"PourcelPourcel8","tweeter_id":"778532048948649984","geo":{"lt":null,"ln":null},"followers":7},"tweet_id":"897898257967218688"},{"url":"http:\/\/twitter.com\/OncotargetJrnl\/statuses\/900045009042452486","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-22T17:20:26+00:00","author":{"name":"Oncotarget","url":"http:\/\/www.oncotarget.com","image":"https:\/\/pbs.twimg.com\/profile_images\/912805301438615553\/9p6BCK3K_normal.jpg","description":"#Scholarly #Medical #Journal","id_on_source":"OncotargetJrnl","tweeter_id":"702864980362702849","geo":{"lt":42.76756,"ln":-78.74392,"country":"US"},"followers":1628},"tweet_id":"900045009042452486"},{"url":"http:\/\/twitter.com\/JPMM_MD_CICS\/statuses\/900889905500274689","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T01:17:45+00:00","author":{"name":"@CICS MD JP","url":"http:\/\/www.cicsonusa.org","image":"https:\/\/pbs.twimg.com\/profile_images\/907031788207226880\/i9WWS_Sa_normal.jpg","description":"Binational IMMUNOONCOLOGY research & care alliance from Seattle & Sonora. We care about life with purpose in cancer patients & relapse prevention.","id_on_source":"JPMM_MD_CICS","tweeter_id":"764944969727475712","geo":{"lt":null,"ln":null},"followers":2117},"tweet_id":"900889905500274689"},{"url":"http:\/\/twitter.com\/rosascorp\/statuses\/900890085264166912","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T01:18:28+00:00","author":{"name":"Martin Orlando Rosas","url":"http:\/\/www.cicson.org","image":"https:\/\/pbs.twimg.com\/profile_images\/747279515265597441\/cFcHll97_normal.jpg","description":"I'm MD working clinically, academically & scientifically at the OMA\/CICS group in immunooncology","id_on_source":"rosascorp","tweeter_id":"144625451","geo":{"lt":29.33333,"ln":-110.66667,"country":"MX"},"followers":405},"tweet_id":"900890085264166912"},{"url":"http:\/\/twitter.com\/CICS_DR_MARQUEZ\/statuses\/900892429884080128","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T01:27:47+00:00","author":{"name":"CICS Sonora & USA","url":"http:\/\/www.cicsonusa.org","image":"https:\/\/pbs.twimg.com\/profile_images\/907387845605711872\/7EFMUd95_normal.jpg","description":"We are Physician Scientists performing clinically relevant oncology research for childhood & adult cancer. We belong to the binational IMMUNOONCOLOGY alliance.","id_on_source":"CICS_DR_MARQUEZ","tweeter_id":"744606863224774656","geo":{"lt":null,"ln":null},"followers":2510},"tweet_id":"900892429884080128"},{"url":"http:\/\/twitter.com\/Diana_CICS\/statuses\/900892492224188417","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T01:28:02+00:00","author":{"name":"Nutritionist Diana G","url":"http:\/\/cicson.org","image":"https:\/\/pbs.twimg.com\/profile_images\/844434621391613955\/8QBqI_uE_normal.jpg","description":"I'm performing the pharmacokinetics of phytochemicals with anti cancer properties. I'm developing clinical oncology nutrition work at CICS MX \ud83c\udf3f\ud83c\udf4e","id_on_source":"Diana_CICS","tweeter_id":"782113152498487296","geo":{"lt":29.33333,"ln":-110.66667,"country":"MX"},"followers":427},"tweet_id":"900892492224188417"},{"url":"http:\/\/twitter.com\/CICS_DrJulioC\/statuses\/900893396021026816","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T01:31:38+00:00","author":{"name":"Julio C\u00e9sar Villegas","image":"https:\/\/pbs.twimg.com\/profile_images\/839248015546183680\/u9PTtB_E_normal.jpg","description":"I'm a PhD performing clinical relevant cancer research at CICS MX & USA.","id_on_source":"CICS_DrJulioC","tweeter_id":"811930819803516929","geo":{"lt":null,"ln":null},"followers":1387},"tweet_id":"900893396021026816"},{"url":"http:\/\/twitter.com\/Agutierrez_83\/statuses\/900897993381081088","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T01:49:54+00:00","author":{"name":"Lic.Alejandro Gtz","image":"https:\/\/pbs.twimg.com\/profile_images\/814203413302939649\/w069lmC7_normal.jpg","description":"Research funding  I'm in charge to optimize funding resources at CICS for clinical relevant research.","id_on_source":"Agutierrez_83","tweeter_id":"746176298465140736","geo":{"lt":29.33333,"ln":-110.66667,"country":"MX"},"followers":279},"tweet_id":"900897993381081088"},{"url":"http:\/\/twitter.com\/PGVM_CICS\/statuses\/900902183285149696","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T02:06:33+00:00","author":{"name":"Perla G Villalobos","image":"https:\/\/pbs.twimg.com\/profile_images\/882762740179324929\/dYwxVr9L_normal.jpg","description":"Medical Student in preparation in the oncology and immunooncology at CICS","id_on_source":"PGVM_CICS","tweeter_id":"838255642519318528","geo":{"lt":null,"ln":null},"followers":509},"tweet_id":"900902183285149696"},{"url":"http:\/\/twitter.com\/CICS_DLAF\/statuses\/900910234675236865","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T02:38:32+00:00","author":{"name":"Diana Ay\u00f3n","image":"https:\/\/pbs.twimg.com\/profile_images\/864167035684638720\/gg2Fm5pH_normal.jpg","description":"I'm performing my social service in clinical pathology laboratory at CICS MX","id_on_source":"CICS_DLAF","tweeter_id":"828996313131806721","geo":{"lt":null,"ln":null},"followers":939},"tweet_id":"900910234675236865"},{"url":"http:\/\/twitter.com\/ChoreGalaz\/statuses\/900910359044816896","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T02:39:02+00:00","author":{"name":"Chore Galaz","image":"https:\/\/pbs.twimg.com\/profile_images\/605872364656553985\/tASwWiL5_normal.png","description":"Cocino, Comparto y me Gana la Risa.","id_on_source":"ChoreGalaz","tweeter_id":"112563284","geo":{"lt":null,"ln":null},"followers":384},"tweet_id":"900910359044816896"},{"url":"http:\/\/twitter.com\/FGM_CICS\/statuses\/900916072429367297","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T03:01:44+00:00","author":{"name":"Francisco Gojon","url":"http:\/\/www.cicson.org","image":"https:\/\/pbs.twimg.com\/profile_images\/885592834295832576\/Mn8-1ER6_normal.jpg","description":"Medical student in preparation in the oncology and immunology at CICS l  ULSA Victoria.","id_on_source":"FGM_CICS","tweeter_id":"838542288594878464","geo":{"lt":29.33333,"ln":-110.66667,"country":"MX"},"followers":493},"tweet_id":"900916072429367297"},{"url":"http:\/\/twitter.com\/LorenaMontijo\/statuses\/900921804075565057","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T03:24:31+00:00","author":{"name":"Lorena Montijo","image":"https:\/\/pbs.twimg.com\/profile_images\/865015154789961728\/KVydcNnB_normal.jpg","description":"CancerVac Fellow, Sonora Cancer Research Center","id_on_source":"LorenaMontijo","tweeter_id":"621575514","geo":{"lt":null,"ln":null},"followers":566},"tweet_id":"900921804075565057"},{"url":"http:\/\/twitter.com\/AL_CICS\/statuses\/900963106905509888","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T06:08:38+00:00","author":{"name":"Ana Ligia Fimbres","url":"http:\/\/cicson.org","image":"https:\/\/pbs.twimg.com\/profile_images\/878679492968857600\/ZNwxxXVW_normal.jpg","description":"Medical student at CEUX","id_on_source":"AL_CICS","tweeter_id":"836989197583966208","geo":{"lt":29.33333,"ln":-110.66667,"country":"MX"},"followers":202},"tweet_id":"900963106905509888"},{"url":"http:\/\/twitter.com\/MAT_CICS\/statuses\/900967122272112640","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T06:24:35+00:00","author":{"name":"Mario Trujillo","url":"http:\/\/cicsonusa.org","image":"https:\/\/pbs.twimg.com\/profile_images\/874415494601744384\/r7FEwjZT_normal.jpg","description":"I am a MD student from Xochicalco medical school & student member of CICS MX & USA. \ud83c\uddf2\ud83c\uddfd\ud83c\uddfa\ud83c\uddf8  CancerVac Fellow. Focus:immunooncology.","id_on_source":"MAT_CICS","tweeter_id":"752230911110844416","geo":{"lt":29.33333,"ln":-110.66667,"country":"MX"},"followers":743},"tweet_id":"900967122272112640"},{"url":"http:\/\/twitter.com\/AGL_CICS\/statuses\/901175691978387456","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T20:13:22+00:00","author":{"name":"Alexa Gomez Lopez","image":"https:\/\/pbs.twimg.com\/profile_images\/836993555310661632\/PSXh_H0K_normal.jpg","description":"Medical student in preparation in the oncology and immunooncology at CICS","id_on_source":"AGL_CICS","tweeter_id":"836992099077672961","geo":{"lt":null,"ln":null},"followers":380},"tweet_id":"901175691978387456"},{"url":"http:\/\/twitter.com\/cpjorgelopez\/statuses\/901219413998882816","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-25T23:07:06+00:00","author":{"name":"CP. Jorge A. L\u00f3pez","image":"https:\/\/pbs.twimg.com\/profile_images\/752564182076170240\/0kHut9D3_normal.jpg","description":"I'm happy to help in cancer phylanthropic initiatives & promote institutional collaborations.","id_on_source":"cpjorgelopez","tweeter_id":"3042307915","geo":{"lt":null,"ln":null},"followers":288},"tweet_id":"901219413998882816"},{"url":"http:\/\/twitter.com\/yvano07\/statuses\/901490414770765825","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-26T17:03:58+00:00","author":{"name":"Ivan rojas","image":"https:\/\/pbs.twimg.com\/profile_images\/861746734078189569\/MXNvBbjw_normal.jpg","description":"hello,  I perform immunooncology lab research at CICS USA.","id_on_source":"yvano07","tweeter_id":"262958474","geo":{"lt":29.33333,"ln":-110.66667,"country":"MX"},"followers":225},"tweet_id":"901490414770765825"},{"url":"http:\/\/twitter.com\/patologia_oma\/statuses\/901579837621534721","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-26T22:59:18+00:00","author":{"name":"Jose Antonio Matute","image":"https:\/\/pbs.twimg.com\/profile_images\/879368433661562882\/YNs3f9CF_normal.jpg","description":"I'm the medical co-director & Immunoonco pathologists of the OMA\/CICS oncology group. My passion: tumor inmune infiltrations","id_on_source":"patologia_oma","tweeter_id":"794331460098363392","geo":{"lt":29.33333,"ln":-110.66667,"country":"MX"},"followers":396},"tweet_id":"901579837621534721"},{"url":"http:\/\/twitter.com\/CICS_TSA\/statuses\/901666269811707904","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-27T04:42:45+00:00","author":{"name":"Tania Santana A","url":"http:\/\/cicson.org","image":"https:\/\/pbs.twimg.com\/profile_images\/893564294519902208\/ZyXn5Ga5_normal.jpg","description":"I'm MD performing clinical & research work. My interest is head and neck Cancer. Work at CICS MX.","id_on_source":"CICS_TSA","tweeter_id":"782317546988908544","geo":{"lt":null,"ln":null},"followers":572},"tweet_id":"901666269811707904"},{"url":"http:\/\/twitter.com\/TR_CICS\/statuses\/901922538896412676","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-27T21:41:04+00:00","author":{"name":"Thal\u00eda Res\u00e9ndez","url":"http:\/\/www.cicson.org","image":"https:\/\/pbs.twimg.com\/profile_images\/878340117554843648\/cznanCJv_normal.jpg","description":"Medical student in preparation in oncology and immunology at CICS | ULSA Victoria","id_on_source":"TR_CICS","tweeter_id":"838594203013763075","geo":{"lt":null,"ln":null},"followers":227},"tweet_id":"901922538896412676"},{"url":"http:\/\/twitter.com\/YC_CICS\/statuses\/902014213048152068","license":"gnip","rt":["OncotargetACD"],"citation_ids":[21263974],"posted_on":"2017-08-28T03:45:21+00:00","author":{"name":"Yoselin Cortez","image":"https:\/\/pbs.twimg.com\/profile_images\/881042645346246656\/8s9Swudh_normal.jpg","description":"Medical student in preparation in the oncology and immunology at CICS | Universidad La Salle, Victoria| F 3:14","id_on_source":"YC_CICS","tweeter_id":"838472742496239619","geo":{"lt":23.74174,"ln":-99.14599,"country":"MX"},"followers":243},"tweet_id":"902014213048152068"},{"url":"http:\/\/twitter.com\/ImmunePC_Papers\/statuses\/906500704709181440","license":"gnip","citation_ids":[21263974],"posted_on":"2017-09-09T12:53:04+00:00","author":{"name":"ImmunePCPapers","image":"https:\/\/pbs.twimg.com\/profile_images\/686611418108407809\/IkK2E3oo_normal.jpg","description":"Twitterbot #PC papers #PubMed RSS | \u22652016 | #PlasmaCells are specialized #Bcells that secrete #antibody | Curated @mmw_lmw","id_on_source":"ImmunePC_Papers","tweeter_id":"4735354746","geo":{"lt":null,"ln":null},"followers":53},"tweet_id":"906500704709181440"},{"url":"http:\/\/twitter.com\/OncotargetACD\/statuses\/907168837212282880","license":"gnip","rt":["ImmunePC_Papers"],"citation_ids":[21263974],"posted_on":"2017-09-11T09:07:59+00:00","author":{"name":"Oncotarget ACD","url":"http:\/\/www.impactjournals.com\/oncotarget\/index.php?journal=oncotarget&page=pages&op=view&path%5B%5D=","image":"https:\/\/pbs.twimg.com\/profile_images\/897050007932723201\/5tB9mCZx_normal.jpg","description":"This section of Oncotarget deals with the latest developments in Autophagy and Cell Death Research, not necessarily related to oncology.","id_on_source":"OncotargetACD","tweeter_id":"3400234997","geo":{"lt":null,"ln":null},"followers":4421},"tweet_id":"907168837212282880"},{"url":"http:\/\/twitter.com\/pmarignani\/statuses\/907170067124817920","license":"gnip","citation_ids":[21263974],"posted_on":"2017-09-11T09:12:53+00:00","author":{"name":"Paola Marignani","url":"https:\/\/marignanilab.com","image":"https:\/\/pbs.twimg.com\/profile_images\/892168339195383808\/oULWijjF_normal.jpg","description":"Scientist discovering something new about signalling networks, cancers and neurodegenerative diseases everyday. #MarignaniLab 55%\/55","id_on_source":"pmarignani","tweeter_id":"32908477","geo":{"lt":60.10867,"ln":-113.64258,"country":"CA"},"followers":649},"tweet_id":"907170067124817920"}]}}